Active Sites Display

WP_172844424.1:JDJFOMJM_01363
Sequence length: 1092 aa
3 domain hit(s)
This protein was scanned against CAZyme family profile alignments to identify conserved domains. Each hit below shows a region of the query that aligns to a known CAZyme family. Within each family profile, certain residues are known or predicted to be catalytic — directly involved in the enzyme's chemical reaction. The sequence display compares these critical positions between the query protein and the family consensus:
Match: the query has the expected catalytic residue, suggesting this active site is conserved and likely functional.
Mismatch: the query has a different residue at this position, which may indicate altered activity, a non-functional site, or subfamily variation.
Gap: the catalytic position in the profile has no corresponding residue in the query alignment, suggesting a deletion or truncation in this region.
Match
Mismatch
Gap
Active Site Conservation Analysis
EntryClassNameDomain RangeCoverageConservationCat. SitesMatches
IPR000514GHGlycoside hydrolase, family 391–157100%40%10
IPR006101GHGlycoside hydrolase, family 2815–830100%42.9%20
PF03633GHGlycosyl hydrolase family 65, C-terminal domain547–109296.9%71.4%00
Domain coverage (1–1092 aa)
IPR000514 — Glycoside hydrolase, family 39 (domain 1–157)
Cross-ref: InterPro: IPR000514
GO: GO:0004553 hydrolase activity, hydrolyzing O-glycosyl compoundsGO:0005975 carbohydrate metabolic process
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 10 Query: MTDTKEELQG TEEGVYLFPL SYAQQRLWFL DQFMPGNPAY NISTAVRLNG TLHSDQLLHA LRQIAVRHET LCTSFREVDG VAMQVIDPSI SLQLPLIDLS ALSKEEQQAR VAAQITSQAQ EPFDLKTAPL LRLTLLKLSE VEHVLLLTMH HIISDGWSMN VLIYELSQLY NAALSGEEAV LPELVIQYAD FGDWQKEYLE SGVLTEQLSY WRDKLGGKLP ILQLPADHKR PAVQSYNGAL ETFLVPARLA DQLRTLSQGE GVSLFMTLLA AFKTLLFRYT GQQDQLVGTP IAGRTREEIE PLIGFFVNTL VMRTELTEDM SFRTLLQRVK DTAFEAYAHQ DVPFEKLVEE LAPERNISHT PLFQVMFNLQ NASVENLSLT GLTLEALDAD TGSSSFDLTL SMTEGKAGIS GRIEYSTDLF ERTTIQRMIP HFLTLLEALA GNPDLELAAL PLLTAEERKL VIETFNDTEA DFRTDLCMHQ MFELQVQKTP DTVAVEHLEE RITYAELNAR ANQLAHYLQE MGIGPEKLVG LCMNRSINLI IGLLGILKAG GAFLPLDPDY PAERLRYLLN DSGVSVLLTE SELLERLPEH SANVVCIDRD GDKIDSFATE NCESGVGPEN LAYLIYTSGS TGAPKGAMLE HRNAVSHHYG VIDRYNVTAS DRIVQFTSIS FDVTVEEIFP TLATGATLVL RPQKTLMASD EFLAWLTEQR ITKFNPPTAY VQTFLRDLAE LKLSLPPTLR LMIAGGERAL PSMIRSWREV ATEHNLLYNG YGPTETTVTA TVYNEELPDD DVPIGRPVAN SQTYVLDVRL QPVPIGIPGE LYIGGRNVGR GYLGRPDLTA ERFVQNPFRV GERMYKTGDI VRFLPDGNLQ FIGRADGQVK IRGYRIELGE IENALSEAPG VREAVVIDRE DIPEQKYLAA YVTLQSAELT AGDLRKHLAQ RLPEYMIPSA FVIMDEMPMT PNGKVNRKEL PRPDDDRPEL GNAYIAPRTD LERSIAEIWQ EVLGVSRVGI HDNFFELGGG SLLILQVHRQ LKENLGIETS VVQLFQYPTV GTLAKFLGDD AEEISVKQGQ DRADRRKDLK SRRAARTKNR RE Profile: ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·D········ ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ··
query > profileE142>D3
IPR006101 — Glycoside hydrolase, family 2 (domain 815–830)
Cross-ref: InterPro: IPR006101
GO: GO:0004553 hydrolase activity, hydrolyzing O-glycosyl compoundsGO:0005975 carbohydrate metabolic process
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 10 Query: MTDTKEELQG TEEGVYLFPL SYAQQRLWFL DQFMPGNPAY NISTAVRLNG TLHSDQLLHA LRQIAVRHET LCTSFREVDG VAMQVIDPSI SLQLPLIDLS ALSKEEQQAR VAAQITSQAQ EPFDLKTAPL LRLTLLKLSE VEHVLLLTMH HIISDGWSMN VLIYELSQLY NAALSGEEAV LPELVIQYAD FGDWQKEYLE SGVLTEQLSY WRDKLGGKLP ILQLPADHKR PAVQSYNGAL ETFLVPARLA DQLRTLSQGE GVSLFMTLLA AFKTLLFRYT GQQDQLVGTP IAGRTREEIE PLIGFFVNTL VMRTELTEDM SFRTLLQRVK DTAFEAYAHQ DVPFEKLVEE LAPERNISHT PLFQVMFNLQ NASVENLSLT GLTLEALDAD TGSSSFDLTL SMTEGKAGIS GRIEYSTDLF ERTTIQRMIP HFLTLLEALA GNPDLELAAL PLLTAEERKL VIETFNDTEA DFRTDLCMHQ MFELQVQKTP DTVAVEHLEE RITYAELNAR ANQLAHYLQE MGIGPEKLVG LCMNRSINLI IGLLGILKAG GAFLPLDPDY PAERLRYLLN DSGVSVLLTE SELLERLPEH SANVVCIDRD GDKIDSFATE NCESGVGPEN LAYLIYTSGS TGAPKGAMLE HRNAVSHHYG VIDRYNVTAS DRIVQFTSIS FDVTVEEIFP TLATGATLVL RPQKTLMASD EFLAWLTEQR ITKFNPPTAY VQTFLRDLAE LKLSLPPTLR LMIAGGERAL PSMIRSWREV ATEHNLLYNG YGPTETTVTA TVYNEELPDD DVPIGRPVAN SQTYVLDVRL QPVPIGIPGE LYIGGRNVGR GYLGRPDLTA ERFVQNPFRV GERMYKTGDI VRFLPDGNLQ FIGRADGQVK IRGYRIELGE IENALSEAPG VREAVVIDRE DIPEQKYLAA YVTLQSAELT AGDLRKHLAQ RLPEYMIPSA FVIMDEMPMT PNGKVNRKEL PRPDDDRPEL GNAYIAPRTD LERSIAEIWQ EVLGVSRVGI HDNFFELGGG SLLILQVHRQ LKENLGIETS VVQLFQYPTV GTLAKFLGDD AEEISVKQGQ DRADRRKDLK SRRAARTKNR RE Profile: ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ···N·····Y ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ··
query > profileG824>N10R830>Y16
PF03633 — Glycosyl hydrolase family 65, C-terminal domain (domain 547–1092)
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 10 Query: MTDTKEELQG TEEGVYLFPL SYAQQRLWFL DQFMPGNPAY NISTAVRLNG TLHSDQLLHA LRQIAVRHET LCTSFREVDG VAMQVIDPSI SLQLPLIDLS ALSKEEQQAR VAAQITSQAQ EPFDLKTAPL LRLTLLKLSE VEHVLLLTMH HIISDGWSMN VLIYELSQLY NAALSGEEAV LPELVIQYAD FGDWQKEYLE SGVLTEQLSY WRDKLGGKLP ILQLPADHKR PAVQSYNGAL ETFLVPARLA DQLRTLSQGE GVSLFMTLLA AFKTLLFRYT GQQDQLVGTP IAGRTREEIE PLIGFFVNTL VMRTELTEDM SFRTLLQRVK DTAFEAYAHQ DVPFEKLVEE LAPERNISHT PLFQVMFNLQ NASVENLSLT GLTLEALDAD TGSSSFDLTL SMTEGKAGIS GRIEYSTDLF ERTTIQRMIP HFLTLLEALA GNPDLELAAL PLLTAEERKL VIETFNDTEA DFRTDLCMHQ MFELQVQKTP DTVAVEHLEE RITYAELNAR ANQLAHYLQE MGIGPEKLVG LCMNRSINLI IGLLGILKAG GAFLPLDPDY PAERLRYLLN DSGVSVLLTE SELLERLPEH SANVVCIDRD GDKIDSFATE NCESGVGPEN LAYLIYTSGS TGAPKGAMLE HRNAVSHHYG VIDRYNVTAS DRIVQFTSIS FDVTVEEIFP TLATGATLVL RPQKTLMASD EFLAWLTEQR ITKFNPPTAY VQTFLRDLAE LKLSLPPTLR LMIAGGERAL PSMIRSWREV ATEHNLLYNG YGPTETTVTA TVYNEELPDD DVPIGRPVAN SQTYVLDVRL QPVPIGIPGE LYIGGRNVGR GYLGRPDLTA ERFVQNPFRV GERMYKTGDI VRFLPDGNLQ FIGRADGQVK IRGYRIELGE IENALSEAPG VREAVVIDRE DIPEQKYLAA YVTLQSAELT AGDLRKHLAQ RLPEYMIPSA FVIMDEMPMT PNGKVNRKEL PRPDDDRPEL GNAYIAPRTD LERSIAEIWQ EVLGVSRVGI HDNFFELGGG SLLILQVHRQ LKENLGIETS VVQLFQYPTV GTLAKFLGDD AEEISVKQGQ DRADRRKDLK SRRAARTKNR RE Profile: ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ··
query > profile
↑ Top





v1.01 @copyright 2026 UCLA